Aspira Women's Health Lands $1.05M Subordinated Loan, Interest Costs $441K
AWHL has more than doubled off its 52-week low of $0.16.
Summary
Aspira Women's Health secured a $1.05 million subordinated term loan from Agile Lending, effective July 1, 2026, maturing January 26, 2027. The note carries expected interest charges of $441,000 if paid on schedule, implying a high effective interest rate. Proceeds will refinance a prior January loan and support general corporate purposes. This follows a $1.49 million private placement in June at $0.45 per share, a premium to the current $0.39 price. The company continues to patch together financing amid a going concern warning and Nasdaq delisting risk, with the loan's subordinated status and high interest costs underscoring its constrained access to capital.
At the time of this announcement, AWHL was trading at $0.39 on OTC in the Life Sciences sector, with a market capitalization of approximately $16.9M. The 52-week trading range was $0.16 to $0.71. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.